BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37291462)

  • 1. Population Pharmacokinetic Model of Methotrexate in Brazilian Pediatric Patients with Acute Lymphoblastic Leukemia.
    de Oliveira Henz P; Pinhatti AV; Gregianin LJ; Martins M; Curra M; de Araújo BV; Dalla Costa T
    Pharm Res; 2023 Jul; 40(7):1777-1787. PubMed ID: 37291462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia.
    Medellin-Garibay SE; Hernández-Villa N; Correa-González LC; Morales-Barragán MN; Valero-Rivera KP; Reséndiz-Galván JE; Ortiz-Zamudio JJ; Milán-Segovia RDC; Romano-Moreno S
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):21-31. PubMed ID: 31673826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic study of methotrexate in children with acute lymphoblastic leukemia.
    Zhang C; Zhai S; Yang L; Wu H; Zhang J; Ke X
    Int J Clin Pharmacol Ther; 2010 Jan; 48(1):11-21. PubMed ID: 20040335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding hemoglobin contribution to high-dose methotrexate disposition-population pharmacokinetics in pediatric patients with hematological malignancies.
    Škorić B; Jovanović M; Kuzmanović M; Miljković B; Vučićević K
    Eur J Clin Pharmacol; 2024 May; 80(5):697-705. PubMed ID: 38347227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
    Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
    Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic study of delayed methotrexate excretion in children with acute lymphoblastic leukemia
.
    Zang YN; Wang SZ; Qin Y; Zhang JR; Zhao LB; Wang XL
    Int J Clin Pharmacol Ther; 2019 Aug; 57(8):402-407. PubMed ID: 31232278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
    Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
    Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of methotrexate in paediatric patients with acute lymphoblastic leukaemia and malignant lymphoma.
    Zhan M; Sun Y; Zhou F; Wang H; Chen Z; Yan L; Li X
    Xenobiotica; 2022 Mar; 52(3):265-273. PubMed ID: 35446233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW; Hulot JS; Urien S; Morel V; Kaloshi G; Fernandez C; Xuan kH; Leblond V; Lechat P
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
    Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between MTHFR microRNA binding site polymorphisms and methotrexate concentrations in Chinese pediatric patients with acute lymphoblastic leukemia.
    Wang SM; Zeng WX; Wu WS; Sun LL; Yan D
    J Gene Med; 2017 Nov; 19(11):353-359. PubMed ID: 28990296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
    Plard C; Bressolle F; Fakhoury M; Zhang D; Yacouben K; Rieutord A; Jacqz-Aigrain E
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):609-20. PubMed ID: 17195068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Study and Individual Dose Adjustments of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia or Osteosarcoma.
    Hui KH; Chu HM; Fong PS; Cheng WTF; Lam TN
    J Clin Pharmacol; 2019 Apr; 59(4):566-577. PubMed ID: 30556906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Population pharmacokinetics of high-dose methotrexate administered in 329 children with acute lymphoblastic leukemia].
    Zhang CY; Gu J; Li YZ; Lu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):106-10. PubMed ID: 18315911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia.
    Gao X; Qian XW; Zhu XH; Yu Y; Miao H; Meng JH; Jiang JY; Wang HS; Zhai XW
    Front Pharmacol; 2021; 12():701452. PubMed ID: 34326772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma.
    Mei S; Li X; Jiang X; Yu K; Lin S; Zhao Z
    J Pharm Sci; 2018 May; 107(5):1454-1460. PubMed ID: 29331383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SLCO1B1 Polymorphisms on High-Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma.
    Schulte RR; Choi L; Utreja N; Van Driest SL; Stein CM; Ho RH
    Clin Transl Sci; 2021 Jan; 14(1):343-353. PubMed ID: 32961024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach.
    Odoul F; Le Guellec C; Lamagnère JP; Breilh D; Saux MC; Paintaud G; Autret-Leca E
    Fundam Clin Pharmacol; 1999; 13(5):595-604. PubMed ID: 10520733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia.
    Ylinen E; Jahnukainen K; Saarinen-Pihkala UM; Jahnukainen T
    Pediatr Blood Cancer; 2014 Dec; 61(12):2199-202. PubMed ID: 25174822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.